9-Nitro-4-(4-nitrophenyl)-3H,3AH,4H,5H,9BH-cyclopenta[C]quinoline-6-carboxylic acid

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: 9-Nitro-4-(4-nitrophenyl)-3H,3AH,4H,5H,9BH-cyclopenta[C]quinoline-6-carboxylic acid
• 英文别名: 9-nitro-4-(4-nitrophenyl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline-6-carboxylic acid
• 化学式: C19H15N3O6
• mdl: MFCD01816945
• 分子量: 381.3
• InChiKey: PJWMSJZDTARCKR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  28
• 可旋转键数：
  2
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.21
• 拓扑面积：
  141
• 氢给体数：
  2
• 氢受体数：
  7

文献信息

• [EN] D-AMINO ACID OXIDASE INHIBITORS FOR LEARNING AND MEMORY<br/>[FR] INHIBITEURS DE D-AMINO ACIDE OXYDASE DESTINES A L'APPRENTISSAGE ET A LA MEMOIRE
  申请人：SEPRACOR INC

  公开号：WO2003039540A2

  公开（公告）日：2003-05-15

  Methods and pharmaceutical compositions which inhibit the activity of D-amino acid oxidase (DAO) are disclosed. Inhibition of DAO improves memory, learning and cognition in individuals suffering from neurodegenerative diseases such as Alzheimer's, Huntington's or Parkinson's diseases; the methods and pharmaceutical compositions which inhibit the activity of DAO also improve cognitive dysfunctions associated with aging and improve catatonic schizophrenia. Several genera of heterocycle-2-carboxylic acids are disclosed as DAO inhibitors.